Immunome, Inc.

General ticker "IMNM" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $730.0M (TTM average)

Immunome, Inc. follows the US Stock Market performance with the rate: 5.8%.

Estimated limits based on current volatility of 2.8%: low 8.39$, high 8.88$

Factors to consider:

  • Earnings expected soon, date: 2025-05-13 bmo
  • Price in estimated range

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-12-31 to 2026-12-31

  • 2024-12-31 to 2025-12-31 estimated range: [4.71$, 12.63$]
  • 2025-12-31 to 2026-12-31 estimated range: [2.89$, 8.24$]

Financial Metrics affecting the IMNM estimates:

  • Negative: Non-GAAP EPS, $ of -2.45 <= 0.04
  • Negative: negative Net income
  • Negative: Operating cash flow per share per price, % of -13.02 <= 1.79
  • Negative: negative Operating income
  • Positive: -3.20 < Investing cash flow per share, $ of -1.45
  • Negative: Industry operating cash flow per share per price (median), % of -21.10 <= 2.82

Similar symbols

Short-term IMNM quotes

2025-03-202025-03-212025-03-242025-03-252025-03-262025-03-272025-03-282025-03-312025-04-012025-04-022025-04-032025-04-042025-04-072025-04-082025-04-092025-04-102025-04-112025-04-142025-04-152025-04-162025-04-172025-04-212025-04-222025-04-232025-04-242025-04-252025-04-282025-04-292025-04-302025-05-0155.566.577.588.59
Price $

Long-term IMNM plot with estimates

510152025Jul 2023Jan 2024Jul 2024Jan 2025Jul 2025Jan 2026Jul 2026Jan 2027−0.8−0.6−0.4−0.20
IMNMS&P500Health CareNon-GAAP EPS EstimateNon-GAAP EPS ActualPrice $Non-GAAP EPS $

Financial data

YTD 2022-12-31 2023-12-31 2024-12-31
Operating Revenue $0.00MM $14.02MM $9.04MM
Operating Expenses $36.90MM $123.55MM $314.84MM
Operating Income $-36.90MM $-109.53MM $-305.80MM
Non-Operating Income $0.01MM $2.75MM $12.87MM
R&D Expense $23.27MM $103.89MM $281.89MM
Income(Loss) $-36.90MM $-106.78MM $-292.93MM
Profit(Loss)* $-37.51MM $-106.81MM $-292.96MM
Stockholders Equity $16.65MM $119.88MM $181.16MM
Inventory $0.85MM $0.00MM $0.00MM
Assets $24.05MM $148.54MM $240.24MM
Operating Cash Flow $-28.69MM $-7.57MM $-110.79MM
Capital expenditure $0.25MM $0.83MM $7.17MM
Investing Cash Flow $-0.25MM $-30.48MM $-85.06MM
Financing Cash Flow $0.03MM $116.41MM $240.53MM
Earnings Per Share** $-3.09 $-5.38 $-5.00

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.